Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple oral doses
of CCX354-C at a number of dose levels in subjects with stable rheumatoid arthritis (RA).